-
-
-
-
-
-
-
BofA Securities Starts Eikon Therapeutics Inc. (EIKN) at Buy
-
-
-
-
-
-
-
Eikon Therapeutics targets $908.2 million valuation in U.S. IPO
-
460,827 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

